Summary
Tranexamic acid is a potent antifibrinolytic drug frequently used in the treatment of haematuria and a number of other haemorrhagic conditions. Since it is eliminated mainly in the urine, the drug accumulates in patients with uraemia. The excretion of tranexamic acid in patients with renal failure has been investigated and dosage recommendations are given for tranexamic acid therapy in cases of renal failure.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Andersson, L., Nilsson, I. M., Colleen, S., Granstrand, B., Melander, B.: Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Annals of the New York Academy of Sciences 146, 642 (1968)
Andersson, L., Nilsson, I. M.: AMCA (aminomethyl cyclohexane carboxylic acid, Cyklo-kapron®) a potent haemostatic agent in urinary tract bleeding. Scandinavian Journal of Urology and Nephrology 3, 169 (1969)
Andersson, L.: Local fibrinolysis. Haemorrhagic and Thrombotic Diseases. London: John Wiley & Sons 1973
Bramsen, T.: Traumatic hyphaema treated with the antifibrinolytic drug tranexamic acid. Acta Ophthalmologica (Kobenhavn) 54, 250 (1976)
Eriksson, O., Kjellman, H., Pilbrant, Å., Schannong, M.: Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. European Journal of Clinical Pharmacology 7, 375 (1974)
Hedlund, P. O.: Antifibrinolytic therapy with Cyklokapron in connection with prostatectomy. A double blind study. Scandinavian Journal of Urology and Nephrology 3, 177 (1969)
Jerndal, T., Frisén, M.: Tranexamic acid (AMCA) and late hyphaema. A double blind study in cataract surgery. Acta Ophthalmologica (Kobenhavn) 54, 417 (1976)
Nilsson, L., Rybo, G.: Treatment of menorrhagia with an antifibrinolytic agent, tranexamic acid (AMCA). A double blind investigation. Acta Obstetricia et Gynecologica Scandinavica 46, 572 (1967)
Rybo, G.: Plasminogen activators in the endometrium. II. Clinical aspects. Acta Obstetricia et Gynecologica Scandinavica 45, 97 (1966)
Rybo, G., Westerberg, H.: The effect of tranexamic acid (AMCA) on postoperative bleeding after conization. Acta Obstetricia et Gynecologica Scandinavica 51, 347 (1972)
Rö, R. S., Knutrud, O., Stormorken, H.: Antifibrinolytic treatment with tranexamic acid (AMCA) in pediatric urinary tract surgery. Journal of Pediatric Surgery 5, 315 (1970)
Tovi, D.: The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage. Acta Neurologica Scandinavica 49, 163 (1973)
Weström, L., Bengtsson, L. P.: Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices. A double blind study. Journal of Reproductive Medicine 5, 154 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andersson, L., Eriksson, O., Hedlund, PO. et al. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. Urol. Res. 6, 83–88 (1978). https://doi.org/10.1007/BF00255578
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00255578